CURRICULUM VITAE Gerald Louis Andriole, Jr., M.D. Address ...
CURRICULUM VITAE Gerald Louis Andriole, Jr., M.D. Address ...
CURRICULUM VITAE Gerald Louis Andriole, Jr., M.D. Address ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
implant) in Community-Based Patients With Advanced Prostate Cancer<br />
Funding Agency:<br />
Oncor (Virco)<br />
Period: 1998-2002<br />
Grant Title:<br />
Detection of Recurrent Bladder Cancer by Microsatellite Analysis of Urinary<br />
Sediment (MAUS)<br />
Funding Agency:<br />
Abbott Laboratories<br />
Period: 2001-2003<br />
Grant Title<br />
M00-244 A Phase III, Randomized, Double-Blind, Placebo-Controlled<br />
Study of the Safety and Efficacy of 10 mg Atrasentan in Men with Non-<br />
Metastatic, Hormone-Refractory Prostate Cancer<br />
Funding Agency:<br />
Barr Laboratories<br />
Period: 1999-2003<br />
Grant Title:<br />
A Phase III, Randomized, Multicenter, Placebo-Controlled, Double-Blind,<br />
Clinical Trial to Study the Efficacy and Safety of CyPat® (Cyproterone Acetate<br />
[CA]) for the Treatment of Hot Flashes Following Surgical or Chemical<br />
Castration of Prostate Cancer Patients and Its Impact on the Quality of Life in<br />
These Patients<br />
Funding Agency:<br />
Ilex Oncology<br />
Period: 1999-2004<br />
Grant Title<br />
Phase III, Randomized, Double-Blind Study of DFMO vs. Placebo in Low Grade<br />
Superficial Bladder Cancer<br />
Funding Agency:<br />
Bard Diagnostic Sciences<br />
Period: 1998-2005<br />
Grant Title:<br />
Use of the Bard BTA Dipstick in Monitoring Superficial Bladder Cancer<br />
Patients Receiving BCG<br />
Funding Agency:<br />
Pharmacia<br />
Period: 2001-2006<br />
Grant Title:<br />
Phase IIb/III Chemoprevention Trial of Celecoxib to Prevent Recurrence In<br />
Superficial Bladder Cancer<br />
Funding Agency:<br />
Zeneca<br />
Period: 1996 - 2000<br />
Grant Title:<br />
A Randomized Double-Blind Comparative Trial of Bicalutamide (Casodex)<br />
versus placebo in Patients with Early Prostate Cancer<br />
Funding Agency:<br />
Johnson & Johnson<br />
Period: 1998-2000<br />
Grant Title:<br />
Controlled Randomized Study Comparing Interstitial Laser Coagulation with the<br />
Indigo Laser System to Transurethral Resection of the Prostate as a Treatment of<br />
Symptoms due to Urinary Outflow Obstruction Secondary to Benign Prostatic<br />
Hyperplasia<br />
Funding Agency:<br />
GlaxoSmithKline<br />
Period: 2003-2006<br />
Grant Title:<br />
A Randomized, Double-Blind, Placebo-Controlled, Parallel<br />
Group Study Of the Efficacy and Safety of Dutasteride 0.5mg<br />
9
Change language